INTRODUCTION
The combination of anxiety with depression is a chronic illness that exacts a significant toll on America's health and productivity. It affects more than 21 million American children and adults annually and is the leading cause of disability in the United States for individuals ages 15 to 44. Lost productive time among U.S. workers due to anxiety and depression is estimated to be in excess of $42 [1] billion per year. Historically, the treatment of anxiety states includes the utilization of antipsychotics, hypnotics and addictive medications. When properly prescribed, the therapeutic approach would include frequent monitoring by a physician and close attention to the expression of side effects caused by medications [2] . The beneficial effects of the primary elements of this compound (GABA [3] , L-theanine [4, 5] , passiflora incarnata [6] , prunus cerasus [7] ) have been postulated to reduce anxiety and depression and have been used to control many of the symptoms associated with these disorders. In as much as each element has been studied *Address correspondence to this author at the Metabolic and Genetic Research Institute, Largo, Florida, USA; E-mail: ifmresearch@aol.com independently, this is the first research project to evaluate the effectiveness of this combination of ingredients. Following an extensive literature search, it is concluded that this combination of elements represents a truly novel and unique compound. This study is being performed to document the METHODS 60 adult participants were randomized into 2 cohorts. 30 subjects received study compound and 30 subjects received placebo (200 mg capsule containing rice flour & gelatin, less than 1 calorie per capsule). All randomized subjects completed the Zung Self-Rating Anxiety Scale (SAS) [8] and the Hamilton Anxiety Rating Scale (HAM-A) [9] prior to randomization and then upon completion of a 7 day course of study compound taken 4 times per day. Individuals were enrolled based upon a self reporting of sign/symptoms of anxiety with our without depression. Those individuals were instructed to also obtain approval from their treating physician in order to continue with the study. All subjects were instructed to maintain their current treatment protocol including any psychoactive medications (antidepressants, anxiolytics and/or hypnotics). The SAS and HAM-A assessments were used to measure the subjective symptomology associated with anxiety and depression (i.e.: "I feel more nervous, I feel afraid for no reason, I get upset, I feel panicky, I feel like I'm falling apart etc.") as well as a measure of somatic signs associated with these feelings (i.e.: "my arms and legs shake and tremble, I have headaches and back pain, I fell my heart racing, I have stomach pain, I have nightmares, etc."). Two separate clinical measures were utilized in order to validate reproducibility and to eliminate bias that may be associated with only one assessment tool. 
RESULTS

Independent
HAM-A SCORES PRE & POST STUDY
ZUNG SAS RESULTS: The Zung SAS symptom scores of all subjects (n=30) receiving active study compound was markedly improved. Global SAS score decreased from an average of 3.6 to 1.4 (an improvement of 61.11%), (p 0.05). Also marked improvement in the following parameters:
I feel more nervous and anxious than usual. Conversely, the placebo group demonstrated a change in the measurement of SAS scores from an average of 3.4 to 3.1 (improvement by 8.82%), n.s.
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CONCLUSIONS
Subjects receiving this unique study compound (GABA, L-theanine, passiflora incarnata and prunus cerasus) received marked improvement in their symptoms of anxiety as demonstrated via two separate and clinically significant assessment tools (HAM-A & Zung SAS) when compared to placebo group. Statistical analysis revealed statistical significance (P 0.05) demonstrating that the study compound has a direct influence in the modulation and improvement of the symptoms associated with anxiety. This combination of natural herbal supplements represents a viable and safe adjunct to the short term treatment of mild to moderate anxiety with or without the use of prescription medication. There were no side effects reported by any of the study participants (n=60).
